Prefilled syringes
663 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by ISIPS
Scoop.it!

Prefilled Syringes Pay Off - Pain Medicine News

Prefilled Syringes Pay Off - Pain Medicine News | Prefilled syringes | Scoop.it
Prefilled Syringes Pay Off Pain Medicine News Denver—Switching to prefilled, ready-to-administer (RTA) syringes can cut related costs by almost 50% and does not require additional space, according to a pharmacist-led study at Brigham and Women's...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Innovation in the Prefilled Syringe Market | video solutions for small businesses

Innovation in the Prefilled Syringe Market http://t.co/TOw2ioS71v
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

BD must still pay $350M+ due to safety syringe spat; other punishments delayed ... - FierceDrugDelivery

BD must still pay $350M+ due to safety syringe spat; other punishments delayed ... - FierceDrugDelivery | Prefilled syringes | Scoop.it
A federal court has upheld the $350 million-plus in damages that Becton Dickinson owes Retractactable Technologies due to a legal spat over drug-delivering prefilled syringes.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

West Offers Innovative and Reliable Solutions at Pre-Filled Syringe ...

West Offers Innovative and Reliable Solutions at Pre-Filled Syringe ... | Prefilled syringes | Scoop.it
West organized the seminar to discuss innovative solutions on prefilled syringe, cartridge and safety devices. Hlobik shared his in-depth knowledge and experience in elastomeric components and accessories to support new ...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

New Developments in Container Closures and Delivery Devices for ...

New Developments in Container Closures and Delivery Devices for ... | Prefilled syringes | Scoop.it
Novartis has introduced a prefilled syringe (PFS) version of Lucentis (ranibizumab) in Germany, with a bespoke syringe designed especially to improve safety as well as dose accuracy. Other examples include the European ...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Vetter Launches New Clinical Syringe Packages - SelectScience.net (press release)

Vetter Launches New Clinical Syringe Packages - SelectScience.net (press release) | Prefilled syringes | Scoop.it
Vetter Launches New Clinical Syringe Packages
SelectScience.net (press release)
Launching directly in a prefilled syringe, when appropriate, rather than vial-only first, can differentiate products in a marketplace hungry for patient-friendly systems.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Novartis Launches Lucentis Prefilled Syringe in Europe - Pharmaceutical Technology Magazine

Novartis Launches Lucentis Prefilled Syringe in Europe
Pharmaceutical Technology Magazine
The innovation reduces non-sterile preparatory steps and includes safety features, such as a non-retractable plunger.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Patient-Centric Design: The Next Frontier In Drug Delivery - Life Science Leader Magazine

Patient-Centric Design: The Next Frontier In Drug Delivery - Life Science Leader Magazine | Prefilled syringes | Scoop.it
Patient-Centric Design: The Next Frontier In Drug Delivery Life Science Leader Magazine Of course if a device is not readily available and the target population cannot easily handle a prefilled syringe, then a more sophisticated device should be...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Universe of Prefilled Syringes and Injection Devices - PDA Europe, Basel 2013

Multiple stakeholders like doctors, patients or payors are demanding enhanced patient adherence and differentiated drugs as values to be demonstrated for new...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife Corp (UNIS): Unilife: My Favorite Speculative Stock Pick For 2014 - Seeking Alpha

Unilife Corp (UNIS): Unilife: My Favorite Speculative Stock Pick For 2014 - Seeking Alpha | Prefilled syringes | Scoop.it
Unilife Corp (UNIS): Unilife: My Favorite Speculative Stock Pick For 2014
Seeking Alpha
So while a company like BD has a standard commodity prefilled syringe that's like every other, Unilife has one with automatic, integrated needle retraction.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife Announces Dismissal of Shareholder Class Action Lawsuit - EIN News (press release)

Unilife Announces Dismissal of Shareholder Class Action Lawsuit EIN News (press release) Unilife's broad portfolio includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Prefilled Syringe Devices, Products, Markets and Forecasts

Prefilled Syringe Devices, Products, Markets and Forecasts | Prefilled syringes | Scoop.it
The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being Now...
more...
No comment yet.
Rescooped by ISIPS from Market Reports
Scoop.it!

Prefilled Syringes Save Billions of Dollars, Reduce Medical Errors | HealthWorks Collective

Prefilled Syringes Save Billions of Dollars, Reduce Medical Errors | HealthWorks Collective | Prefilled syringes | Scoop.it
Within the $70 billion plus global market for injectable drugs, one specialty segment – the prefilled syringe – has garnered noteworthy popularity since the 1980s.

Via wayne collins
more...
wayne collins's curator insight, December 4, 2014 2:36 AM

Within the $70 billion plus global market for injectable drugs, one specialty segment – the prefilled syringe – has garnered noteworthy popularity since the 1980s. Prefilled syringes were introduced during World War II, but it wasn’t until the early 1980s that this injectable drug delivery method started gaining larger exposure. The turning point came when Sanofi and Rhône Poulenc-Rorer launched heparins in the form of prefilled syringes.

 

Read More link http://healthworkscollective.com/varsha-jain/281596/prefilled-syringes-ready-answer-saving-billions-dollars-and-mitigating-medical-er

 

Prior to this, prefilled syringes were viewed mostly as an insignificant niche within the larger market for injectable drugs. The therapeutic scope of prefilled syringes was limited to a smaller range of applications in a few vaccines and anticoagulant products. The demand for prefilled syringes exploded in the following years, and they soon became the container of choice in major therapeutic classes for injectable drug formulations. The major factors that resulted in a breakthrough progress of this technology were the clear advantages presented by prefilled syringes over traditional ampoules and vials.

 

Today, these foundational aspects continue to drive the prefilled syringes market. But given that prefilled syringes have also seamlessly adapted to contemporary medical demands, their popularity doesn’t come as a surprise.

 

Why It’s Hard to Ignore the Advantages of Prefilled Syringes

 

Drug administration via the traditional ampoule and vial method requires adhering to a number of steps such as: reading the required dose prescribed by the physician from a prescription, withdrawing slightly more formulation from the vial than prescribed, inverting the syringe to allow any air bubbles to ascend to the top, depressing the plunger slightly to expel any air, and finally, depressing the plunger slightly further to make the dosage in proportion prescribed by the physician.

 

These steps can be arduous, not to mention error-prone.

 

In contrast, drugs filled in prefilled syringes can be administered merely by removing packaging of the syringe and injecting the formulation. Their single-use, disposable format, combined with the fact that fixed doses of drugs are filled in them mechanically and again cross-checked electronically during quality check, makes their use easy and error-free. Prefilled syringes also reduce the risks of needle-stick injury, which is more likely with traditional formats because they keep the needle tip exposed longer.

 

Another cost-efficient feature of prefilled syringes is the precise amount of drug contained by them. Vials and ampoules have to be filled with more liquid than what is prescribed to be injected so that the correct amount is withdrawn. The excess formulation that gets wasted can be a costly matter, especially when expensive biotech products are considered.

 

Opportunity Alert: Prefilled Syringes in the Critical Care Emergency Drugs Market

 

Combined with the enormous benefits presented by prefilled syringes, it was the emergence of biotechnology drugs during the early 90s that led this market to robust expansion. The market has since continued to grow at a good pace. Analysts suggest that nearly 3 billion prefilled syringes were sold in 2013. Potential growth opportunities in the market suggest that this market could easily notch a demand for nearly 7 billion units by 2019.

 

A lot has been said and written about prefilled syringes over the past decade and a range of new developments have been brought to the market by leading manufacturers. But there is one truly important point that remains unaddressed, by both the consumers and the people administering these drugs: the rare existence of prefilled syringes in the critical care emergency drugs market.

 

The critical care emergency drugs market, not surprisingly, is the area where benefits provided by prefilled syringes could be best exploited to enhance patient care and ensure safety. Drugs used in critical care centers and at emergency situations are such that they can save a life, or may claim one, for instance atropine and ephedrine.

 

The fact remains that a major portion of drugs from this therapeutic class is still prepared and dosed in syringes by critical care nurses around the globe. Syringes filled with such critical care drugs are prepared every day to treat patients and some are filled only on account of an emergency anesthesia or planned surgery.

 

Surveys say that nearly 70% of syringes of atropine dosage prepared for emergency situations are ultimately wasted because of the lack of a necessity during the operating procedure, and lack of evidence of stability and sterility for later use. The demand for atropine (and other critical therapeutic drugs) is huge – millions of atropine glass ampoules are sold every year throughout the world. Wastage of at least 70% of them must be a substantial loss of funds to everybody involved in the chain of treatment. Let’s not forget that risks of glass cuts with these products for the medical staff are also huge.

 

In light of these substantial numbers, there is a pressing need for more prefilled technology in every therapeutic area. Quality-controlled, precisely-filled and large-scale industrially manufactured drugs in prefilled syringes would contribute significantly toward eradicating medical errors, risks of nosocomial infections, and reduce wastage of drugs and supplies at large.

 

Chiefly, they will allow medical staff to save valuable time and attend to patients more effectively – a factor that can make or break equations as important as someone’s life in operation theatres.

 

About Us

Varsha Jain, a writer with Transparency Market Research, holds a prolific understanding of developments in the pharmaceuticals industry and the world of Information Technology – the two foremost industries that drive the 21st century. With an educational background in computer sciences, Varsha has written extensively on market trends in IT and pharmaceuticals, and their collective impact on the economy today.

 

Contact

Ms. Varsha Jain

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

 

Scooped by ISIPS
Scoop.it!

Prefilled Syringes to 2022 - MarketWatch

Prefilled Syringes to 2022 - MarketWatch | Prefilled syringes | Scoop.it
Prefilled Syringes to 2022 MarketWatch As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Prefilled Syringes Market Expected to Reach USD 4.98 Billion ...

Prefilled Syringes Market Expected to Reach USD 4.98 Billion ... | Prefilled syringes | Scoop.it
According to a new market report published by Transparency Market Research “Prefilled Syringes Market (Glass and Plastic) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2013 – 2019,” the ...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in...

This study is designed to determine whether ulcerative colitis participants prefer delivery of golimumab via a prefilled syringe or the Smartject™ device.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

NYPD on Patrol Will Soon Carry Powerful Overdose Antidote Kits - NY City Lens

NYPD on Patrol Will Soon Carry Powerful Overdose Antidote Kits - NY City Lens | Prefilled syringes | Scoop.it
NY City Lens NYPD on Patrol Will Soon Carry Powerful Overdose Antidote Kits NY City Lens Each kit – which costs around $60 – consists of a zippered bag with two prefilled syringes of naloxone, two atomizers for nasal administration, sterile gloves...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife Appoints Dennis Pyers as Interim CFO - MarketWatch

Unilife Appoints Dennis Pyers as Interim CFO - MarketWatch | Prefilled syringes | Scoop.it
Unilife Appoints Dennis Pyers as Interim CFO MarketWatch Unilife's broad portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors,...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife Corporation: How This Hypodermic Needle Company Keeps Jabbing ... - Seeking Alpha

Unilife Corporation: How This Hypodermic Needle Company Keeps Jabbing ... - Seeking Alpha | Prefilled syringes | Scoop.it
Unilife Corporation: How This Hypodermic Needle Company Keeps Jabbing ...
Seeking Alpha
Contentious issues pile up as the prefilled syringe company continues to try to answer an ongoing Securities and Exchange Commission investigation.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife to Present at the Barclays Global Healthcare Conference on March 13th - PharmiWeb.com (press release)

Unilife to Present at the Barclays Global Healthcare Conference on March 13th - PharmiWeb.com (press release) | Prefilled syringes | Scoop.it
Unilife to Present at the Barclays Global Healthcare Conference on March 13th PharmiWeb.com (press release) Unilife's broad portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction drug reconstitution...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife: More contracts to come for Ocu-ject delivery platform - In-PharmaTechnologist.com

Unilife: More contracts to come for Ocu-ject delivery platform - In-PharmaTechnologist.com | Prefilled syringes | Scoop.it
Unilife: More contracts to come for Ocu-ject delivery platform
In-PharmaTechnologist.com
“The overall market is moving to prefilled syringes,” he said.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

West Pharmaceutical Services Inc. (WST) news: Growth Of Injectable Drugs To ... - Seeking Alpha

West Pharmaceutical Services Inc. (WST) news: Growth Of Injectable Drugs To ...
Seeking Alpha
West also offers the following safety systems to prevent needle sticks: Eris™ and B.Safe® for prefilled syringes and NovaGuard™ for luer lock syringes.
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Unilife Corp (UNIS): Unilife: When A 'Growth' Pure-Play Isn't A Smart Play - Seeking Alpha

Unilife Corp (UNIS): Unilife: When A 'Growth' Pure-Play Isn't A Smart Play - Seeking Alpha | Prefilled syringes | Scoop.it
Unilife Corp (UNIS): Unilife: When A 'Growth' Pure-Play Isn't A Smart Play Seeking Alpha Several others have commented on this in depth, pointing out that the market for prefilled syringes is "oligopolistic in nature and is dominated by a few key...
more...
No comment yet.
Scooped by ISIPS
Scoop.it!

Research and Markets: Prefilled Syringe Devices, Products, Markets and Forecasts | Business Wire

Research and Markets: Prefilled Syringe Devices, Products, Markets and Forecasts | Business Wire | Prefilled syringes | Scoop.it
Research and Markets (http://www.researchandmarkets.com/research/6g3k38/prefilled_syringe) has announced the addition of the "Prefilled Syringe D (Research and Markets: Prefilled Syringe Devices, Products, Markets and Forecasts
more...
No comment yet.